Day: July 25, 2022

2 outstanding ASX growth shares brokers rate as buys

Woman looks amazed and shocked as she looks at her laptop.

Woman looks amazed and shocked as she looks at her laptop.

Are you interested in adding some ASX growth shares to your portfolio this week? If you are, you may want to look at the two listed below that have recently been named as buys.

Here’s what you need to know about them:

Altium Limited (ASX: ALU)

The first ASX growth share to look at is Altium. It is a printed circuit board design software (PCB) provider.

PCBs are the boards you find in almost all electronic devices. And as they come in all shapes and sizes and with all kinds of different functions, the design of them is an extremely complex process and requires specialist software.

Through its Altium Designer and Altium 365 software, the company owns industry-leading software which is used by many of the biggest companies and organisations in the world such as NASA and Tesla.

Bell Potter is very positive on Altium and continues to forecast strong earnings growth over the coming years. It also sees upside for the Altium share price with its buy rating and $34.00 price target.

ResMed Inc. (ASX: RMD)

Another ASX growth share to look at is ResMed. It is a medical device company which has a focus on sleep treatment solutions.

Over the last decade, ResMed’s revenue and earnings have grown at a strong rate thanks to the quality of its products and its large and growing market opportunity.

In respect to the latter, management estimates that there are almost one billion people with sleep apnoea globally (with only ~20% diagnosed) and a little under half a billion people suffering from chronic obstructive pulmonary disease (COPD). This gives it a long runway for growth over the 2020s and beyond.

Morgans is a fan of ResMed and currently has an add rating and $37.95 price target on its shares.

The post 2 outstanding ASX growth shares brokers rate as buys appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of July 7 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Altium and ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/V4Gml5x

Expert prediction: 3 ASX 200 shares that can ‘do well’ in volatile times

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.

The S&P/ASX 200 Index (ASX: XJO) has fallen in the year, but experts have tipped three shares that could rise in a high-interest rate environment.

The benchmark ASX 200 index has lost nearly 9% in the year to date and more than 8% over the past 12-months.

So let’s take a look at three ASX 200 shares the experts recommend right now.

What shares are worth investing in?

According to some analysts, shares in CSL Ltd (ASX: CSL), QBE Insurance Group Ltd (ASX: QBE) and Transurban Group (ASX: TCL) could be worth considering.

QBE shares leapt 1.14% on Monday, while Transurban shares were up 1.64% at the close and CSL shares fell 0.84%.

Analysts have named multiple shares that could climb despite higher interest rates, with Investors Mutual senior portfolio manager Hugh Giddy saying in a livewire interview that CSL “might do really well”.

Giddy said that CSL was “a very high margin business” with many research and development costs already “expensed”. He added:

Then they’ve got the plasma donation cost, but that actually could come down because we are heading into harder times.

Meanwhile, Atlas Funds Management chief investment officer Hugh Dive recommended QBE Insurance and Transurban. Commenting on QBE, he said:

I think the insurance companies will do well particularly, for example, QBE. It’s got a US$29 billion float, which has earned close to zero for the last 10 years.

Dive also earmarked Transurban, citing the fact that tolls went up when inflation jumped. Dive noted:

… every year with inflation, the tolls go up. For the next four years, Transurban has said that every 1% increase in inflation equals another US$50 million in profit. So there are companies that do quite well in this environment.

The post Expert prediction: 3 ASX 200 shares that can ‘do well’ in volatile times appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of July 7 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/5efJBUX

Why these blue chip ASX 200 shares are rated as buys by experts

man using laptop happy at rising share price

man using laptop happy at rising share price

With so many blue chip ASX shares to choose from, it can be hard to decide which ones to buy over others.

To help narrow things down, I have picked out two top blue chip ASX shares that experts rate as buys right now. They are as follows:

CSL Limited (ASX: CSL)

The first blue chip ASX share to consider is CSL. It is one of the world’s leading biotechnology companies, comprising the CSL Behring business and the Seqirus business.

The CSL Behring business is the global leader in a plasma therapies industry worth a massive ~US$30 billion per year. Whereas Seqirus is the number two player in the ~US$6 billion global influenza vaccines industry.

While COVID-related plasma collection headwinds have been weighing on CSL’s performance, this headwind is now easing. In fact, industry data appears to show that collections are back to pre-COVID levels at long last. This should be supportive of its margins in the coming years, especially as the company rolls out its new collection technology which is expected to collect plasma more efficiently.

In light of this, investors may want to focus more on the long term, which remains very positive for CSL thanks to strong demand for its portfolio of life-saving therapies and vaccines, its lucrative research and development pipeline, and the impending acquisition of Vifor Pharma.

Citi is positive on CSL and currently has a buy rating and $330.00 price target on its shares.

Goodman Group (ASX: GMG)

Another blue chip ASX share to look at is Goodman Group. It is a leading integrated commercial and industrial property company.

Management has expertly developed its portfolio to give it exposure to key growth markets such as ecommerce and logistics. This has been a huge success and been a key driver of Goodman’s stellar growth in recent years and again in FY 2022.

For example, in FY 2022, strong demand has led to the company upgrading its earnings guidance numerous times. So much so, it now expects earnings per share growth of 20%+ this year.

The team at Citi is also positive on Goodman. Its analysts continue to believe that Goodman’s guidance is conservative and that the company will outperform it. The broker is also forecasting earnings per share growth of almost 20% in FY 2023.

In light of this, it will come as no surprise to learn that Citi has a buy rating and $22.00 price target on Goodman’s shares.

The post Why these blue chip ASX 200 shares are rated as buys by experts appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of July 7 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rvG4Yg9

Here’s why the Pointsbet share price tumbled 10% today

gambling asx share price fall represented by woman in soccer had looking frustrated at tablet screen

gambling asx share price fall represented by woman in soccer had looking frustrated at tablet screen

The Pointsbet Holdings Ltd (ASX: PBH) share price fell more than 10% on Monday. At market close, it finished trading at $2.95.

Pointsbet describes itself as a corporate bookmaker, with operations in Australia, the US, Canada and Ireland.

The small-cap ASX share is scheduled to hand in its FY22 fourth quarter update on 29 July 2022. However, it has been a while since the company released a price-sensitive announcement.

However, it’s not the only small ASX share that is down today. The S&P/ASX 200 Index (ASX: XJO) is down 0.1% and the S&P/ASX Small Ordinaries Index (ASX: XSO) is down 0.75%.

Some of ASX’s other growth shares are also down. The Adore Beauty Group Ltd (ASX: ABY) share price is down 4%, the Temple & Webster Group Ltd (ASX: TPW) share price is down 3.4%, the Cettire Ltd (ASX: CTT) share price is down 14%, the Appen Ltd (ASX: APX) share price is down 15% and the Whispir Ltd (ASX: WSP) share price is down 7.8%.

What’s going on with the Pointsbet share price?

Aside from simply matching the decline of other small cap ASX shares, there could also be an element of profit-taking from some investors.

The Pointsbet share price is still up 10% over the last week and it’s up 18% in the past month.

According to reporting by the Australian Financial Review, bond investors are betting that there is going to be an economic slowdown in the US (and the world), but interest rates may still need to go up to control inflation.

The post Here’s why the Pointsbet share price tumbled 10% today appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of July 7 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Appen Ltd, Cettire Limited, Pointsbet Holdings Ltd, Temple & Webster Group Ltd, and Whispir Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group Limited. The Motley Fool Australia has recommended Adore Beauty Group Limited, Cettire Limited, Pointsbet Holdings Ltd, Temple & Webster Group Ltd, and Whispir Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/iw4VlBK